- Home
- JWEL vs POAI Comparison
JWEL vs POAI Comparison
Compare JWEL & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- POAI
- Stock Information
- Founded
- JWEL 2012
- POAI 2002
- Country
- JWEL China
- POAI United States
- Employees
- JWEL N/A
- POAI N/A
- Industry
- JWEL Other Consumer Services
- POAI Industrial Specialties
- Sector
- JWEL Consumer Discretionary
- POAI Health Care
- Exchange
- JWEL Nasdaq
- POAI Nasdaq
- Market Cap
- JWEL 4.1M
- POAI 4.9M
- IPO Year
- JWEL 2021
- POAI N/A
- Fundamental
- Price
- JWEL $1.95
- POAI $0.69
- Analyst Decision
- JWEL
- POAI Hold
- Analyst Count
- JWEL 0
- POAI 1
- Target Price
- JWEL N/A
- POAI N/A
- AVG Volume (30 Days)
- JWEL 16.1K
- POAI 119.5K
- Earning Date
- JWEL 11-29-2024
- POAI 11-12-2024
- Dividend Yield
- JWEL N/A
- POAI N/A
- EPS Growth
- JWEL N/A
- POAI N/A
- EPS
- JWEL N/A
- POAI N/A
- Revenue
- JWEL $160,009,293.00
- POAI $1,484,223.00
- Revenue This Year
- JWEL N/A
- POAI N/A
- Revenue Next Year
- JWEL N/A
- POAI $502.91
- P/E Ratio
- JWEL N/A
- POAI N/A
- Revenue Growth
- JWEL N/A
- POAI N/A
- 52 Week Low
- JWEL $1.00
- POAI $0.55
- 52 Week High
- JWEL $3.14
- POAI $3.76
- Technical
- Relative Strength Index (RSI)
- JWEL 54.81
- POAI 44.88
- Support Level
- JWEL $1.81
- POAI $0.70
- Resistance Level
- JWEL $2.15
- POAI $0.89
- Average True Range (ATR)
- JWEL 0.18
- POAI 0.11
- MACD
- JWEL 0.01
- POAI 0.00
- Stochastic Oscillator
- JWEL 49.09
- POAI 14.64
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.